Phase Two Safety and Efficacy Study of Single Dose Intravesical Resiniferatoxin in Patients with Interstitial Cystitis
Payne C1, Mosbaugh P2, Forrest J3, Evans R3, Frumkin L4 1. Stanford University, 2. Indiana University, 3. none, 4. ICOS Corporation
Abstract Category
Painful Bladder Syndromes/IC
|
Abstract 148
|
|
Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein
Scientific Podium Poster Session 16
|
|
Friday 27th August 2004 |
|
15:09 - 15:17 |
|